Review Article

Sex Differences in Drug Disposition

Table 3

Sex differences in hepatic clearance by route of metabolism/elimination.

PHASE I ENZYMES
Metabolic routeModel substratesDrugs metabolized by routeSex-specific activity

CYP1ACaffeine, nicotine paracetamol (acetaminophen)Clomipramine, clozapine, olanzapine, paracetamol, tacrine, theophyllineM > F [65]
CYP2C9Dapsone, (S)-mephenytoinIbuprofen, (S)-warfarin, tolbutamide, fluvastatin, glipizide, losartan, irbesartan, piroxicam, tolbutamide, phenytoin, fluvastatin, nelfinavirM = F [66]
CYP2C19(S)-Mephenytoin DiazepamLansoprazole, omeprazole, hexobarbital, mephobarbital, citalopram, celecoxib, irbesartan, imipramine, piroxicam, propranolol (in part)M = F [67]
CYP2D6Dextromethorphan, debrisoquine, sparteineCodeine, encainide, flecainide, fluoxetine, hydrocodone, metoprolol, paroxetine, mexilitine, phenformin, propranolol, sertraline, timolol, haloperidol, clomipramine, desipramine, imipramine, propafenone, testosteroneM < F [68]
CYP2E1Chlorzoxazoneā€”M > F [69]
CYP3AMidazolam, dapsone, cortisol, Lidocaine, nifedipine, erythromycinAlprazolam, alfentanil, astemizole, atorvastatin, carbamazepine, cisapride, clarithromycin, cyclosporin, cyclophosphamide, diazepam,diltiazem, erythromycin, estradiol, fentanyl, indinavir, itraconazole, ketoconazole, lovastatin, quinidine, nimodipine, nisoldipine, quinidine, ritonavir, verapamil, tacrolimus, simvastatin, vincristine, vinblastine, tamoxifen, tirilazad, troglitazoneF > M [70]

PHASE II ENZYMES
Metabolic routeModel substratesDrugs metabolized by routeSex-specific activity

UDP-glucuronosyl-transferasesCaffeineClofibric acid, diflusinal, ibuprofen, mycophenolate, mofetil, paracetamol, zidovudineM = F [68, 71]
SulfotransferasesCaffeineā€”M > F [72]
N-Acetyl-transferasesCaffeine, dapsoneCatecholamine derivatives, mercaptopurine, isoniazid, hydralazineM = F [73]
Methyl-transferasesNorepinehrine, epinephrineAzathioprine, dopamine, levodopa, 6-mercaptopurine, thioguanine, tazathioprineM > F [74]

Table modified from Soldin and Mattison [5].